Key facts
- Notable investors include Arben Ventures, Life Changing Labs.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Progenic Genomics
- ·The full record, as it builds
Funding rounds
No funding rounds for Progenic Genomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Progenic Genomics
Developer of a genomics analysis platform designed for reproductive health. The company's platform analyzes whole genome data from prospective parents and embryos, integrating genetic health risks and other factors to provide a comprehensive health score, enabling prospective parents and clinics to reduce the risk of genetic diseases in embryos.
- Sector
- Healthcare
- HQ
- Sausalito, CA, United States
- Founded
- 2021
- Employees
- 2
- Website
- progenicgenomics.com/
- Ownership
- Privately Held (backing)
Progenic Genomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Progenic Genomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Progenic Genomics in its N-PORT filings yet. We sweep new filings monthly.